Mechanisms of diabetic complications
- PMID: 23303908
- DOI: 10.1152/physrev.00045.2011
Mechanisms of diabetic complications
Abstract
It is increasingly apparent that not only is a cure for the current worldwide diabetes epidemic required, but also for its major complications, affecting both small and large blood vessels. These complications occur in the majority of individuals with both type 1 and type 2 diabetes. Among the most prevalent microvascular complications are kidney disease, blindness, and amputations, with current therapies only slowing disease progression. Impaired kidney function, exhibited as a reduced glomerular filtration rate, is also a major risk factor for macrovascular complications, such as heart attacks and strokes. There have been a large number of new therapies tested in clinical trials for diabetic complications, with, in general, rather disappointing results. Indeed, it remains to be fully defined as to which pathways in diabetic complications are essentially protective rather than pathological, in terms of their effects on the underlying disease process. Furthermore, seemingly independent pathways are also showing significant interactions with each other to exacerbate pathology. Interestingly, some of these pathways may not only play key roles in complications but also in the development of diabetes per se. This review aims to comprehensively discuss the well validated, as well as putative mechanisms involved in the development of diabetic complications. In addition, new fields of research, which warrant further investigation as potential therapeutic targets of the future, will be highlighted.
Similar articles
-
Complications of type 1 diabetes.Endocrinol Metab Clin North Am. 2010 Sep;39(3):625-40. doi: 10.1016/j.ecl.2010.05.009. Endocrinol Metab Clin North Am. 2010. PMID: 20723824 Review.
-
AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):913-9. doi: 10.1016/j.numecd.2013.04.004. Epub 2013 Jun 17. Nutr Metab Cardiovasc Dis. 2013. PMID: 23786818 Review.
-
Microvascular complications of diabetes.Endocrinol Metab Clin North Am. 2004 Mar;33(1):215-38, xi-xii. doi: 10.1016/j.ecl.2003.12.003. Endocrinol Metab Clin North Am. 2004. PMID: 15053904 Review. No abstract available.
-
Metabolic memory: implications for diabetic vascular complications.Pediatr Diabetes. 2009 Aug;10(5):343-6. doi: 10.1111/j.1399-5448.2008.00491.x. Pediatr Diabetes. 2009. PMID: 19490497 Review. No abstract available.
-
Current concepts of diabetes mellitus.Int Ophthalmol Clin. 1998 Spring;38(2):1-10. Int Ophthalmol Clin. 1998. PMID: 9604734 Review. No abstract available.
Cited by
-
Glycation of fibronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-c-Src crosstalk.J Cell Mol Med. 2020 Aug;24(16):9154-9164. doi: 10.1111/jcmm.15552. Epub 2020 Jul 1. J Cell Mol Med. 2020. PMID: 32613750 Free PMC article.
-
Evidence for human diabetic cardiomyopathy.Acta Diabetol. 2021 Aug;58(8):983-988. doi: 10.1007/s00592-021-01705-x. Epub 2021 Mar 31. Acta Diabetol. 2021. PMID: 33791873 Free PMC article. Review.
-
Elevated 4-hydroxynonenal induces hyperglycaemia via Aldh3a1 loss in zebrafish and associates with diabetes progression in humans.Redox Biol. 2020 Oct;37:101723. doi: 10.1016/j.redox.2020.101723. Epub 2020 Sep 16. Redox Biol. 2020. PMID: 32980661 Free PMC article.
-
A Role of Glucose Overload in Diabetic Cardiomyopathy in Nonhuman Primates.J Diabetes Res. 2021 Mar 30;2021:9676754. doi: 10.1155/2021/9676754. eCollection 2021. J Diabetes Res. 2021. PMID: 33860059 Free PMC article. Review.
-
Type 2 Diabetes Mellitus Trajectories and Associated Risks.Big Data. 2016 Mar 1;4(1):25-30. doi: 10.1089/big.2015.0029. Big Data. 2016. PMID: 27158565 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical